Skip to content
Open access

A-179: Co-Development of a Pilot Pediatric Neuropsychological Assessment Protocol in Myotonic Dystrophy Type 1

Oct 2026 · Archives of Clinical Neuropsychology · 0 citations

Abstract

Objective: Myotonic dystrophy type 1 (DM1) is a rare neuromuscular disorder affecting multiple organ systems, with high prevalence in the Saguenay–Lac-Saint-Jean region (Canada). Pediatric forms are more severe than adult-onset cases, leading to cognitive and social impairments that hinder academic achievement and integration. Despite these challenges, this population remains understudied, highlighting the need for standardized, age-appropriate assessment protocols to support inclusion in clinical trials. This pilot study aimed to co-develop and evaluate a neuropsychological assessment protocol for children and adolescents with DM1. Method/Data Selection: Parent and patient partners, along with clinicians specializing in pediatric neuropsychology and DM1, co-developed a cross-sectional pilot protocol. The battery assesses intellectual, attentional, executive, social, and motor domains, as well as daytime sleepiness, using validated standardized measures. Non-invasive neurophysiological measures, including portable EEG and eye tracking, were included to characterize attentional and socio-emotional processes. The protocol was designed for implementation in youth with DM1 and age- and sex-matched typically developing controls. Results/Data Synthesis: The co-development process produced a standardized pilot protocol targeting domains identified as clinically meaningful by stakeholders. The final protocol integrates neuropsychological (e.g., WISC-V, NEPSY-II) and neurophysiological measures. It documents acceptability and feasibility while providing an initial descriptive characterization of cognitive functioning in youth with DM1. Conclusions: This study establishes a methodological foundation for assessing children and adolescents with DM1. By combining neuropsychological and neurophysiological measures in a co-developed, clinically relevant protocol, it enables future large-scale studies to refine the cognitive and socio-emotional profile of this population, inform tailored assessment tools and interventions, and support families and educational settings.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.